Restorative Therapies, Inc., Receives FDA Clearance for RT300-S Internet Connectivity

Share Article

Restorative Therapies, Inc., a designer and supplier of medical devices, today announced FDA clearance of internet connectivity for its breakthrough medical device, the RT300-S, a functional electrical stimulation (FES) motorized cycle ergometer.

Restorative Therapies, Inc., founded by John McDonald, MD, PhD, Lead Neurologist to the Late Christopher Reeve, Advances its New Era in Treatment for Neurological Injury and Paralysis.

Restorative Therapies, Inc., a designer and supplier of medical devices, today announced FDA clearance of internet connectivity for its breakthrough medical device, the RT300-S, a functional electrical stimulation (FES) motorized cycle ergometer.

In the treatment of neurological damage, FES is used to restore motor functions to previously paralyzed muscles. The RT300-S delivers electrical currents to activate the quadriceps, hamstring and gluteal muscles, enabling paralyzed legs to move through a regular patterned physical activity.

Internet connectivity now allows clinicians to control RT300-S therapy parameters remotely. Both patients and clinicians are able to monitor therapy progress no matter where the patient lives. As patients use the RT300-S, performance data is continuously collected. Once a therapy session has been completed, this performance data along with a number of key outcome measures are stored into a central database.

“For most patients, this is a long term therapy and providing ongoing clinical supervision via the RT300-S internet connectivity will allow us to optimize patient outcomes.” says John McDonald, MD, PhD, founder of Restorative Therapies, Inc., and director of the International Center for Spinal Cord Injury at the Kennedy Krieger Institute in Baltimore. “Outcome data collected from so many patients will also be a valuable research tool.” McDonald concludes.

“Internet connectivity also enhances the safety and efficiency of delivering RT300-S therapy within a clinical environment.” says Andrew Barriskill, CEO of Restorative Therapies. “RTI is now working to ensure that clinical programs are established to take full advantage of the ability of this new system to deliver improved outcomes for all RT300-S patients.”

About Restorative Therapies, Inc.

Restorative Therapies (http://www.restorative-therapies.com), is a privately-held company headquartered in Baltimore, Md., whose mission is to help people with neurological impairment achieve their full recovery potential. Restorative Therapies is one of the first companies to target activity-based therapy and FES as a treatment for immobility associated with paralysis such as stroke and spinal cord injury.

Restorative Therapies is now also selling the RT300-S directly into Canada and has recently appointed Cyclone Mobility as their UK distributor. Further European rollout is expected during 2006.

About Dr. John McDonald

John W. McDonald, MD, PhD, directs the International Center for Spinal Cord Injury at Kennedy Krieger Institute. From 1998-2004, prior to joining Kennedy Krieger, he founded and served as director of the Spinal Cord Injury Program at Washington University School of Medicine in St. Louis. His work has been recognized by many organizations, including the National Institutes of Health, International Neurotrauma Society and American Academy of Neurology.

Dr. McDonald also leads multi-center clinical trials in spinal cord injury repair. He has completed six trials to date, including the first human stem cell transplantation study and an investigation into the effectiveness of restorative therapy in 60 adults with spinal cord injuries. Dr. McDonald and his team at Kennedy Krieger will soon join a prospective, multi-center trial evaluating the efficacy of restorative therapies in children.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Judy Kline
Visit website